227 related articles for article (PubMed ID: 3864396)
1. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
2. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
[TBL] [Abstract][Full Text] [Related]
3. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
[No Abstract] [Full Text] [Related]
4. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
5. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
6. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
[TBL] [Abstract][Full Text] [Related]
7. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
8. High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.
Kern W; Schleyer E; Unterhalt M; Wörmann B; Büchner T; Hiddemann W
Cancer; 1997 Jan; 79(1):59-68. PubMed ID: 8988727
[TBL] [Abstract][Full Text] [Related]
9. [High-dose treatment].
Takaku F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
[TBL] [Abstract][Full Text] [Related]
10. [A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
Miyawaki S; Mizoguchi H; Tomonaga M; Kanamaru A; Tsukagoshi S; Nakamura T; Ohashi Y; Yoshida S; Ohno R
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2229-42. PubMed ID: 9881080
[TBL] [Abstract][Full Text] [Related]
11. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
Willemze R; Fibbe WE; Zwaan FE
Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
[No Abstract] [Full Text] [Related]
12. Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.
Al Bahar S; Pandita R; Bavishi K; Savani B
Neoplasma; 1999; 46(1):61-5. PubMed ID: 10355536
[TBL] [Abstract][Full Text] [Related]
13. [Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia].
Ohshima A; Yoshida K; Sato T; Miyazaki S; Yanagisawa M; Nakayama Y; Takahashi T; Mamiya S; Fukusima Y; Miura AB
Gan To Kagaku Ryoho; 1987 Jan; 14(1):192-5. PubMed ID: 3800405
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of high doses vs conventional doses of cytosine arabinoside combined with cisplatin and dexamethasone in patients with refractory lymphoma].
Avilés A; García EL; Guzmán R; Talavera A; Poot JJ; Díaz-Maqueo JC
Rev Invest Clin; 1991; 43(2):146-50. PubMed ID: 1947469
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia].
Saito K; Furusawa S; Yamada K; Waga K; Aoyagi A; Koike T; Arimura H; Noguchi M; Yamato H; Sakuma H
Rinsho Ketsueki; 1995 Mar; 36(3):165-74. PubMed ID: 7540220
[TBL] [Abstract][Full Text] [Related]
16. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
Sanz MA; Borrego D; Martín-Aragonés G; Martínez JA; Lorenzo I; Sanz G; Sayas MJ; Jarque I; Pastor E; Rafecas J
Sangre (Barc); 1987; 32(4):476-81. PubMed ID: 3660187
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
[TBL] [Abstract][Full Text] [Related]
18. [Results in the treatment of acute leukemias at the Internal Clinic B in the period 1970-1975].
Ruvidić R; Bosković D
Bilt Hematol Transfuz; 1976; 4(1-2):37-42. PubMed ID: 1066123
[TBL] [Abstract][Full Text] [Related]
19. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
[No Abstract] [Full Text] [Related]
20. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
Peters WG; Willemze R; Colly LP; Guiot HF
Neth J Med; 1987 Feb; 30(1-2):64-74. PubMed ID: 3473310
[No Abstract] [Full Text] [Related]
[Next] [New Search]